Albemarle Growth and Economic Outlook

Specialties Overview Y/Y Q3 Performance Drivers Net sales down -20% (price³ -13%, volume -7%); adjusted EBITDA down 65% Decreased sales due to lower volumes and prices impacted by weaker demand, particularly for consumer electronics Adjusted EBITDA impacted by weakness in certain end-use markets including consumer, industrial electronics, and elastomers FY 2023 Outlook (as of Nov 1, 2023) Specialties FY 2023 adj. EBITDA expected to be down 40-45% Y/Y, down from previous outlook Continued softness in consumer electronics and elastomers; stronger demand in other Specialties end-markets, including oilfield services, agriculture, and pharmaceuticals Operating normally at JBC (Jordan Bromine Company); monitoring potential impacts of the current situation in the Middle East Drivers/Sensitivities GDP+ growth with diverse applications and end-markets in mobility, energy, connectivity, and health Supported by underlying trends in digitalization and electrification Note: Numbers may not reconcile due to rounding. 1 Net of FX impacts. 2 Sales based on historical average. 3 Includes FX impact. 4 See appendix for non-GAAP reconciliations. Q3 2023 Performance (in millions) Net Sales Q3 2023 Y/Y $353 -20% Net Sales ex FX1 $352 -20% Adj. EBITDA4 $46 -65% Adj. EBITDA ex FX1,4 $53 -60% Adj. EBITDA Margin4 13% -1730 bps Adj. EBITDA Margin ex FX1.4 15% -1530 bps Historical Trend (TTM) Adjusted EBITDA ● Adjusted EBITDA Margin $543M $527M $537M $450M 32% $362M 31% 30% 27% 23% 3Q22 4Q22 1Q23 2Q23 3Q23 Albemarle 30

View entire presentation